Almirall, S.A. (FRA:E2Z)
12.82
+0.08 (0.63%)
Last updated: Jan 28, 2026, 8:23 AM CET
Almirall Employees
Almirall had 2,084 employees as of June 30, 2025. The number of employees increased by 58 or 2.86% since the number was reported on December 31, 2024.
Employees
2,084
Change
58
Growth
2.86%
Revenue / Employee
€535,551
Profits / Employee
€20,754
Market Cap
2.71B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 2,084 | 58 | 2.86% |
| Dec 31, 2024 | 2,026 | 122 | 6.41% |
| Dec 31, 2023 | 1,904 | 58 | 3.14% |
| Dec 31, 2022 | 1,846 | 60 | 3.36% |
| Dec 31, 2021 | 1,786 | -1 | -0.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| Mainova AG | 3,416 |
| Gelsenwasser AG | 1,898 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Lechwerke AG | 459 |
| Northern Data AG | 199 |
Almirall News
- 12 days ago - Almirall, S.A. (LBTSF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - Almirall, S.A.: Almirall Announces "LumiNE", a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema - Finanz Nachrichten
- 17 days ago - Almirall Announces "LumiNE", a Phase III Clinical Study Assessing the Efficacy of Lebrikizumab for the Treatment of Nummular Eczema - Benzinga
- 18 days ago - Almirall, S.A.: Almirall Presents R&D Pipeline Advances Supported by Sustained Growth and Leadership in Medical Dermatology at J.P. Morgan Healthcare Conference - Finanz Nachrichten
- 2 months ago - Almirall, S.A. (LBTSF) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Almirall SA (FRA:E2Z) Q3 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... - GuruFocus
- 2 months ago - Q3 2025 Almirall SA Earnings Call Transcript - GuruFocus
- 2 months ago - Almirall, S.A. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha